GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting to discuss the financial results for the quarter and half-year.

The company is engaging with institutional investors through scheduled analyst meetings to share publicly available information.

No new operational changes, business developments, or financial impacts were disclosed.